XAVEJMA Trademark
Trademark Overview
On Tuesday, October 18, 2022, a trademark application was filed for XAVEJMA with the United States Patent and Trademark Office. The USPTO has given the XAVEJMA trademark a serial number of 97636870. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, June 11, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The XAVEJMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use...
General Information
| Serial Number | 97636870 |
| Word Mark | XAVEJMA |
| Filing Date | Tuesday, October 18, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, June 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 2, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 28, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 21, 2022 | NEW APPLICATION ENTERED |
| Wednesday, November 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 28, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, April 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 27, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 2, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 2, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Saturday, December 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 18, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, June 18, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, December 21, 2023 | SOU EXTENSION 1 FILED |
| Thursday, December 21, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 13, 2024 | SOU EXTENSION 3 FILED |
| Friday, December 13, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, June 11, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 11, 2025 | SOU EXTENSION 4 FILED |
| Wednesday, June 11, 2025 | SOU EXTENSION 4 GRANTED |
